Amzak Health Investors
VC Fund
New York, United States
Amzak Health Investors is a VC fund in New York focused on Biotechnology and Medical. Amzak Health invests across the healthcare sector including therapeutics, devices, diagnostics, and services. The Amzak Health principals have invested in over 50 healthcare companies since 2005.
- Total investments:
- 24
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Amzak Health Investors invests in
Stages Amzak Health Investors invests in
Countries Amzak Health Investors invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Margarita C. Bernard
|
|||
Joyce Erony
|
|||
Investment Focus
Industry
- Biotechnology 10 (42%)
- Medical 9 (38%)
- Health Care 7 (29%)
- Medical Device 6 (25%)
- Therapeutics 4 (17%)
Stage
- Series B 8 (33%)
- Series A 5 (21%)
- Series C 2 (8%)
- Series D 2 (8%)
- Post-IPO Equity 2 (8%)
Country
- United States 10 (42%)
- Canada 4 (17%)
- Germany 1 (4%)
- Switzerland 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Margarita C. Bernard
Office Manager
|
Office Manager | Total investments: 0 | Find email | |
Anders Hove
Managing Partner
|
Managing Partner | Total investments: 15 | Find email | |
|
Joyce Erony
Managing Partner & Founder
|
Managing Partner & Founder | Total investments: 9 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Nervonik
|
Nervonik is a medical device company developing an opioid-free peripheral nerve stimulation (PNS) system. Nervonik is focused on advancing clinical research and achieving regulatory milestones to bring its innovative therapies to market. | $52.5M / Series B / Apr 27, 2026 | |
HistoSonics
|
HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels. | Private Equity / Aug 07, 2025 | |
Neuros Medical
|
Neuros Medical is a neuromodulation company, is focused on developing proprietary therapies for the unmet needs of patients worldwide. The Company's patented platform technology, Electrical Nerve Block, is focused on the elimination of chronic pain in a variety of applications including neuroma/residual limb pain, chronic post-surgicalpain, and chronic migraine. | $56M / Series D / Jul 09, 2025 | |
Sound Blade Medical
|
Sound Blade Medical is an early stage medical device startup that revolutionizes healthcare by enhancing endoscopic, image-guided histotripsy. | $16.5M / Series A / Jan 29, 2025 | |
ShiraTronics
|
ShiraTronics is in the early stages of developing new innovative therapies to combat debilitating migraine headaches. The company is focused on commercializing novel neuromodulation technologies to treat this large unmet clinical need for patients and physicians. ShiraTronics is the first spinout from NuXcel a global medical device acceleratorcompany. | $66M / Series B / Sep 30, 2024 | |
|
HistoSonics
|
HistoSonics provides the Edison Platform, which uses advanced imaging and proprietary sensing technology to deliver non-invasive, personalized treatments with precision and control, and uses the science of histotripsy and focused sound energy to generate pressures to liquify and completely destroy targeted tissues at sub-cellular levels. | $102M / Series D / Aug 15, 2024 | |
Synergy Disc Replacement Inc
|
Synergy Disc Replacement Inc(SDRI) produces Cervical disc implant to restore patient's balance, range of motion and alignment. | $30M / Series A / Jan 31, 2024 | |
Gynesonics
|
Gynesonics is a women’s healthcare company focused on the development of advanced incision-free solutions for the treatment of uterine conditions. Gynesonics serves customers worldwide. It was founded in 2005 and is headquartered in Redwood City, California. | $42.5M / Oct 25, 2023 | |
Miach Orthopaedics
|
Miach Orthopaedics is a medical device company that develops bio-engineered surgical implants to facilitate new tissue growth. The company's product is the Bridge-Enhanced ACL Repair technology as a viable alternative to conventional ACL reconstruction for patients who have withstand an anterior cruciate ligament injury.Miach Orthopaedicswas founded on 2016 and is headquartered in Westborough, Massachusetts. | $30M / Series B / Jan 25, 2023 | |
Antios Therapeutics
|
Antios Therapeutics is a biopharmaceutical company devoted to developing innovative therapies for viral diseases. With an experienced and proven leadership team, the company is focused on the development of its oral drug candidate for potentially curative treatment of HBV infections.Antios Therapeutics was founded by Abel De La Rosa, DouglasMayers, and Idean Marvasty. | $75M / Series B / Nov 03, 2021 | |
| See all 24 investments → | |||
Co-Investors
Lumira Ventures
8 deals together
Aisling Capital
6 deals together
U.S. Venture Partners
5 deals together
Aperture Venture Partners
4 deals together
Fonds de solidarité FTQ
4 deals together
Google Ventures
4 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Amzak Health Investors invest in?
Amzak Health Investors invests primarily in Biotechnology, Medical and Health Care startups, most often at Series B and Series A stage. Most of the 24 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Amzak Health Investors?
Public channels for Amzak Health Investors include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Amzak Health Investors?
The team at Amzak Health Investors includes Margarita C. Bernard (Office Manager), Anders Hove (Managing Partner) and Joyce Erony (Managing Partner & Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
